Amplify Treatments, Testing and Advancements ETF Rating → Elon to Transform U.S. Economy? (From Porter & Company) (Ad) Free GERM Stock Alerts $18.40 +0.26 (+1.43%) (As of 05/3/2024 08:52 PM ET) Add Compare Share Share RatingsStock AnalysisChartHoldingsRatingsStock AnalysisChartHoldingsRatings Amplify Treatments, Testing and Advancements ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.GERM Aggregate RatingModerate Buy2.55Holdings in GERM have an aggregate rating of Moderate Buy based on 324 analyst ratings issued in the past year covering 44 companies (94.4% of the portfolio).GERM Aggregate Price Target$31.4070.66% UpsideHigh Prediction$46.05Average Prediction$31.40Low Prediction$22.56Holdings in GERM have an aggregate price target of $31.40 and a range of $22.56 to $46.05 covering 44 companies (94.4% of the portfolio).GERM Consensus Ratings of HoldingsStrong Buy1 Strong Buy rating(s)Buy12 Buy rating(s)Moderate Buy15 Moderate Buy rating(s)Hold15 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell1 Strong Sell rating(s) Ratings for Stocks Held by Amplify Treatments, Testing and Advancements ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 44 GERM Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings7.30%MRNAModerna$125.00-0.5%3 of 5 stars2.25$129.55 3.6%16Earnings ReportAnalyst ReportInsider SellingAnalyst Revision6.83%DGXQuest Diagnostics$137.38+0.8%5 of 5 stars2.25$146.17 6.4%12Analyst Downgrade6.48%BNTXBioNTech$92.72+0.5%3 of 5 stars2.30$120.40 29.9%106.35%ALNYAlnylam Pharmaceuticals$152.33+1.3%5 of 5 stars2.59$215.88 41.7%17Earnings ReportAnalyst ReportGap Up6.20%LHLaboratory Co. of America$201.32+0.5%5 of 5 stars2.79$243.14 20.8%144.93%IBRXImmunityBio$9.15+2.0%0 of 5 stars2.00$6.00 -34.4%1Upcoming EarningsGap Up4.01%DVAXDynavax Technologies$11.74+0.2%4 of 5 stars2.75$25.00 112.9%4Upcoming Earnings3.80%BIOBio-Rad Laboratories$279.83+0.2%5 of 5 stars2.80$468.00 67.2%5Upcoming Earnings3.80%QDELQuidelOrtho$42.50+0.7%5 of 5 stars2.00$61.60 44.9%7Upcoming EarningsGap Down3.67%IMCRImmunocore$60.23+1.3%3 of 5 stars2.87$80.92 34.4%15Upcoming EarningsAnalyst Revision3.65%PCVXVaxcyte$65.96+2.2%1 of 5 stars3.00$78.50 19.0%4Upcoming EarningsGap Up2.97%ZLABZai Lab$16.25-2.0%2 of 5 stars3.00$64.22 295.2%5Upcoming EarningsPositive News2.80%VIRVir Biotechnology$10.39+13.2%3 of 5 stars2.57$33.57 223.1%7Earnings ReportAnalyst ReportGap Up2.48%OPKOPKO Health$1.305 of 5 stars3.00$3.17 143.6%3Upcoming Earnings2.38%BCRXBioCryst Pharmaceuticals$4.45-0.7%4 of 5 stars3.00$13.83 210.9%6Gap Up1.81%ARCTArcturus Therapeutics$27.27+2.8%2 of 5 stars3.00$61.33 124.9%7Upcoming EarningsGap Up1.57%FLGTFulgent Genetics$21.50+1.2%4 of 5 stars2.00$30.00 39.5%2Gap Down1.55%HLVXHilleVax$13.61-2.9%3 of 5 stars3.00$30.67 125.3%3Upcoming Earnings1.45%NVAXNovavax$4.93+4.7%4 of 5 stars3.00$17.00 244.8%2Gap Up1.42%CVACCureVac$3.13+13.0%4 of 5 stars2.00$8.33 166.2%5Gap UpHigh Trading Volume1.19%ABUSArbutus Biopharma$2.71+1.1%2 of 5 stars3.00$4.33 59.9%3Analyst Report1.01%OSUROraSure Technologies$5.49+0.2%4 of 5 stars2.33$6.38 16.1%3Upcoming Earnings0.99%AZNAstraZeneca$76.35+0.7%2 of 5 stars2.57$81.00 6.1%7Gap Up0.97%ALTAltimmune$7.30+1.5%1 of 5 stars2.50$15.00 105.5%4Upcoming EarningsGap Up0.91%MRKMerck & Co., Inc.$127.51-0.6%5 of 5 stars2.58$131.33 3.0%120.90%ADPTAdaptive Biotechnologies$3.01+2.7%4 of 5 stars2.67$6.80 125.9%6Upcoming EarningsGap Up0.90%PFEPfizer$27.81+0.4%5 of 5 stars2.38$36.00 29.4%16Earnings ReportAnalyst Revision0.89%LLYEli Lilly and Company$734.97-2.8%5 of 5 stars2.84$757.95 3.1%19Earnings ReportAnalyst Revision0.89%SNYSanofi$49.01-0.9%3 of 5 stars2.40$55.00 12.2%5Gap Up0.88%OCGNOcugen$1.33+0.8%1 of 5 stars3.00$4.67 250.9%3Gap Up0.88%GSKGSK$43.50+0.3%3 of 5 stars2.405Dividend Increase0.87%ABBVAbbVie$163.79+1.9%4 of 5 stars2.77$174.31 6.4%13Earnings Report0.86%REGNRegeneron Pharmaceuticals$957.00+2.1%4 of 5 stars2.70$981.71 2.6%20Analyst Report0.85%GILDGilead Sciences$64.78-0.8%5 of 5 stars2.39$83.69 29.2%180.84%JNJJohnson & Johnson$149.27-0.4%5 of 5 stars2.46$175.86 17.8%130.83%ABTAbbott Laboratories$105.900.0%5 of 5 stars2.67$121.50 14.7%90.81%AVIRAtea Pharmaceuticals$3.96+3.4%0 of 5 stars1.001Upcoming Earnings0.75%CRMDCorMedix$5.84+8.8%2 of 5 stars3.00$13.00 122.6%4Positive NewsGap Up0.73%ENTAEnanta Pharmaceuticals$15.17+9.1%3 of 5 stars2.17$19.33 27.4%6News Coverage0.66%IVVDInvivyd$2.42+2.1%1 of 5 stars3.00$11.33 368.3%3Upcoming EarningsGap Up0.57%INOInovio Pharmaceuticals$12.10+0.7%3 of 5 stars2.67$96.00 693.4%3Upcoming Earnings0.33%VXRTVaxart$0.73-2.7%1 of 5 stars3.00$3.00 311.6%2Gap Up0.27%EBSEmergent BioSolutions$3.89+17.9%4 of 5 stars2.00$5.00 28.5%2Earnings ReportGap UpHigh Trading Volume0.21%IFRXInflaRx$1.383 of 5 stars3.50$13.50 878.3%2Upcoming Earnings This page (NYSEARCA:GERM) was last updated on 5/6/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyThe asset beating inflation by 4xColonial MetalsCould Your Accounts Be Frozen?Allegiance GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithIs Tesla going out of business?DTIStock-Picking AI Predicts #1 Stock of 2024Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amplify Treatments, Testing and Advancements ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
